| Dr John Thomas Pessoney, MD | |
|
5912 Old Mobile Highway, Suite 1, Pascagoula, MS 39581 | |
| (228) 471-1000 | |
| (228) 471-1039 |
| Full Name | Dr John Thomas Pessoney |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 5912 Old Mobile Highway, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437253515 | NPI | - | NPPES |
| 204642102 | Other | MO | MEDICAID |
| 243419306 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 2003000629 (Missouri) | Secondary |
| 2083X0100X | Preventive Medicine - Occupational Medicine | 20863 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Thomas Pessoney, MD 5912 Old Mobile Hwy, Suite 1, Pascagoula, MS 39581-4520 Ph: (228) 471-1000 | Dr John Thomas Pessoney, MD 5912 Old Mobile Highway, Suite 1, Pascagoula, MS 39581 Ph: (228) 471-1000 |
News Archive
Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI.
Briefly recapping a history of foreign aid policy since 1920, former Sen. Blanche Lincoln (D-Ark.) and former Arkansas Gov. Mike Huckabee (R) write in a Politico opinion piece, "Credit for America's global leadership role belongs to both major political parties and Americans of all stripes" who "have always been guided by the notion that all lives have equal value, regardless of where someone was born."
A shortened pre-surgical interruption of anti-thrombotic therapy, compared to the more traditional one-week interruption, has no influence on perioperative complications in cardiac patients, according to the results of the PRAGUE 14 trial.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Stand Up To Cancer (SU2C) and the Dutch Cancer Society (KWF Kankerbestrijding), along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announce the recipients of the Sta Op Tegen Kanker International Translational Cancer Research Grant.
› Verified 9 days ago
Dr. William Pollock Warfield, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Jerry St. Pe' Hyw., Pascagoula, MS 39568 Phone: 228-935-1383 Fax: 228-933-7370 |